Search
Phibro Animal Health Corp
PAHCAdd to Watchlist
33.140USD
+1.040+3.24%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.34BMarket Cap
14.11P/E TTM
More Details of Phibro Animal Health Corp Company
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corp Info
Ticker SymbolPAHC
Company namePhibro Animal Health Corp
IPO dateApr 11, 2014
CEOBendheim (Jack C)
Number of employees2475
Security typeOrdinary Share
Fiscal year-endApr 11
AddressGlenpointe Centre East, 3Rd Floor
CityTEANECK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07666
Phone12013297300
Websitehttps://www.pahc.com/
Ticker SymbolPAHC
IPO dateApr 11, 2014
CEOBendheim (Jack C)
Company Executives of Phibro Animal Health Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
FAQs
Who are the top five shareholders of Phibro Animal Health Corp?
The top five shareholders of Phibro Animal Health Corp are: Mr. Glenn C. David
How many institutions hold shares of Phibro Animal Health Corp (PAHC)?
As of 2026Q1, 474 institutions hold shares of Phibro Animal Health Corp, with a combined market value of approximately 22.03M, accounting for 104.57% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -645505.00.
What is the biggest source of revenue for Phibro Animal Health Corp?
In 2026Q1, the MFAs and Other business generated the highest revenue for Phibro Animal Health Corp, amounting to 202.11M and accounting for 54.05% of total revenue.